Lidocaine Hydrochloride hydrate
CAS No. 6108-05-0
Lidocaine Hydrochloride hydrate ( —— )
产品货号. M15297 CAS No. 6108-05-0
Lidocaine (Lignocaine) hydrochloride hydrate 抑制涉及复杂电压和依赖性的钠通道 (sodium channels)。Lidocaine hydrochloride hydrate 通过调节 miR-145 表达和进一步抑制 MEK/ERK 和 NF-κB 信号通路来减少胃癌细胞的生长,迁移和侵袭。Lidocaine hydrochloride hydrate 是一种酰胺衍生物,可用于研究室性心律失常。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 10MG | ¥110 | 有现货 |
|
| 25MG | ¥164 | 有现货 |
|
| 50MG | ¥235 | 有现货 |
|
| 100MG | ¥323 | 有现货 |
|
| 500MG | ¥799 | 有现货 |
|
| 1G | ¥1161 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥111 | 有现货 |
|
生物学信息
-
产品名称Lidocaine Hydrochloride hydrate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Lidocaine (Lignocaine) hydrochloride hydrate 抑制涉及复杂电压和依赖性的钠通道 (sodium channels)。Lidocaine hydrochloride hydrate 通过调节 miR-145 表达和进一步抑制 MEK/ERK 和 NF-κB 信号通路来减少胃癌细胞的生长,迁移和侵袭。Lidocaine hydrochloride hydrate 是一种酰胺衍生物,可用于研究室性心律失常。
-
产品描述Lidocaine, an amide local anesthetic, has anti-inflammatory properties in vitro and in vivo, possibly due to an attenuation of pro-inflammatory cytokines, intracellular adhesion molecule-1 (ICAM-1), and reduction of neutrophils influx.(In Vitro):Lidocaine (Lignocaine) (10 nM; 48 hours) decreases significantly cell proliferation.Lidocaine (1-10 nM; 24-72 hours) inhibits cell viability and achieves the most suppressing effects at the concentration of 10?nM and treatment time 48?hours.Lidocaine (10 nM; 48 hours) increases significantly the apoptotic cell rate.Lidocaine (10 nM; 48 hours) down-regulates Cyclin D1 and up-regulates p21 expression significantly.(In Vivo):Lidocaine (Lignocaine) causes completely reversible tail nerve block in rats. Mechanical nociception block produced by lidocaine has slower onset and faster recovery compared with thermal nociception block.
-
体外实验Lidocaine (Lignocaine) (10 nM; 48 hours) decreases significantly cell proliferation. Lidocaine (1-10 nM; 24-72 hours) inhibits cell viability and achieves the most suppressing effects at the concentration of 10?nM and treatment time 48?hours. Lidocaine (10 nM; 48 hours) increases significantly the apoptotic cell rate. Lidocaine (10 nM; 48 hours) down-regulates Cyclin D1 and up-regulates p21 expression significantly. Cell Proliferation Assay Cell Line:The human gastric cancer cell line MKN45 Concentration:10?nM Incubation Time:48 hours Result:Decreased significantly cell proliferation.Cell Viability Assay Cell Line:The human gastric cancer cell line MKN45 Concentration:1, 5 and 10?nMIncubation Time:24, 48, 72 hours Result:Inhibited MKN45 cell viability.Apoptosis Analysis Cell Line:The human gastric cancer cell line MKN45 Concentration:10?nM Incubation Time:48 hours Result:Increased significantly the apoptotic cell rate.Western Blot Analysis Cell Line:The human gastric cancer cell line MKN45 Concentration:10?nM Incubation Time:48 hours Result:Down-regulated Cyclin D1 and up-regulated p21 expression significantly.
-
体内实验Lidocaine (Lignocaine) causes completely reversible tail nerve block in rats. Mechanical nociception block produced by lidocaine has slower onset and faster recovery compared with thermal nociception block.
-
同义词——
-
通路Angiogenesis
-
靶点EGFR
-
受体EGFR| Sodium Channel
-
研究领域Cardiovascular Disease
-
适应症——
化学信息
-
CAS Number6108-05-0
-
分子量288.82
-
分子式C14H22N2O·HCl·H2O
-
纯度>98% (HPLC)
-
溶解度DMSO: 10 mM
-
SMILESO.Cl.CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Sheets PL, et al. J Physiol. 2007 Jun 15;581(Pt 3):1019-3
产品手册
关联产品
-
Vandetanib
Vandetanib 是一种口服生物可利用的 4-苯胺基喹唑啉。 Vandetanib选择性抑制血管内皮生长因子受体2(VEGFR2)的酪氨酸激酶活性,从而阻断VEGF刺激的内皮细胞增殖和迁移,降低肿瘤血管通透性。
-
EGFR-IN-11
EGFR-IN-11 是第四代 EGFR-酪氨酸激酶抑制剂 (EGFR-TKI),对三重突变的 EGFRL858R/T790M/C797S 的 IC50 为 18 nM。EGFR-IN-11 显著抑制 EGFR 磷酸化,诱导细胞凋亡,将细胞周期阻滞在 G0/G1处。
-
Orphenadrine Citrate
Orphenadrine Citrate 是一种骨骼肌松弛剂,它作用于中枢神经系统,产生肌肉松弛作用。
021-51111890
购物车()
sales@molnova.cn

